Pharnext SA
PAR:ALPHA

Watchlist Manager
Pharnext SA Logo
Pharnext SA
PAR:ALPHA
Watchlist
Price: 0.0002 EUR
Market Cap: 1.2k EUR

Operating Margin
Pharnext SA

-17 526.7%
Current
-683 936.6%
Average
-4.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-17 526.7%
=
Operating Profit
-26.3m
/
Revenue
150k

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
FR
Pharnext SA
PAR:ALPHA
1.2k EUR
-17 527%
IL
Can Fite Biopharma Ltd
TASE:CANF
169.9T ILS
-1 487%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
390.1B USD
33%
US
Amgen Inc
NASDAQ:AMGN
174.5B USD
34%
US
Gilead Sciences Inc
NASDAQ:GILD
151.2B USD
39%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.5B USD
39%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.9B USD
28%
AU
CSL Ltd
ASX:CSL
84B AUD
26%
NL
argenx SE
XBRU:ARGX
42.7B EUR
22%
No Stocks Found

Pharnext SA
Glance View

Market Cap
1.2k EUR
Industry
Biotechnology

Pharnext SA develops and manufactures drugs for neurological diseases. The company is headquartered in Issy-Les-Moulineaux, Ile-De-France. The company went IPO on 2016-07-18. The firm is focused on discovering, developing and licensing new therapeutic solutions (Pleodrugs) and companion tests for unmet medical needs (large and niche markets) by using the Pleotherapy approach. Pharnext SA runs all its own activities, from research through to clinical development (no further than the end of Phase II trials), and then licenses the Pleodrugs to industrial partners. The firm's prime focus is on neurodegenerative diseases and metabolic diseases.

ALPHA Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-17 526.7%
=
Operating Profit
-26.3m
/
Revenue
150k
What is the Operating Margin of Pharnext SA?

Based on Pharnext SA's most recent financial statements, the company has Operating Margin of -17 526.7%.

Back to Top